Sagamihara, Japan

Namsoon Kim


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Namsoon Kim

Introduction

Namsoon Kim is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of human cDNAs and the proteins they encode. His work has implications for understanding human biology and developing new therapeutic approaches.

Latest Patents

Namsoon Kim holds a patent titled "Human cDNAs and proteins encoded thereby." This patent involves isolated cDNAs derived from mRNAs expressed in human cells. The patent provides DNAs and RNAs comprising their nucleotide sequences, as well as vectors for expressing the cDNAs. The cDNAs encode proteins that have functions similar to known proteins, highlighting their potential importance in research and medicine. He has 1 patent to his name.

Career Highlights

Namsoon Kim is affiliated with the Sagami Chemical Research Center, where he conducts his research. His work at this institution has allowed him to explore innovative solutions in the field of molecular biology. His research has contributed to a deeper understanding of human proteins and their functions.

Collaborations

Namsoon Kim has collaborated with notable colleagues, including Seishi Kato and Suwan Oh. These collaborations have likely enhanced the scope and impact of his research, fostering a productive environment for innovation.

Conclusion

Namsoon Kim's contributions to the field of biotechnology through his patent and research at the Sagami Chemical Research Center demonstrate his commitment to advancing scientific knowledge. His work continues to influence the understanding of human biology and the development of new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…